- Recent Funding
- Investors
- Yumeng Capital
Yumeng Capital portfolio
Yumeng Capital has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is MegaRobo's $300M Series B+ round in June 2022, alongside Gobi Partners, Sinovation Ventures, Redview Capital and 6 others. That company is in Health and bio.
What Yumeng Capital invests in
- Health and bio · 1 · 100%
- Robotics and hardware · 1 · 100%
How Yumeng Capital invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $300M |
Yumeng Capital portfolio companies
| Company | Round with Yumeng Capital | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $300M | $560M | Nov 19, 2026 round |
Most frequent co-investors
GGoldman Sachs Asset Management1 shared round · last Jun 27, 2022
GGGV Capital1 shared round · last Jun 27, 2022
GGobi Partners1 shared round · last Jun 27, 2022
PPavilion Capital1 shared round · last Jun 27, 2022
SSinovation Ventures1 shared round · last Jun 27, 2022
- RRedview Capital1 shared round · last Jun 27, 2022
- TTaihecap1 shared round · last Jun 27, 2022
HHarvest Capital Management1 shared round · last Jun 27, 2022
- UU-Member Capital1 shared round · last Jun 27, 2022
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
EEquentis5 companies · 4 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Yumeng Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Yumeng Capital, which is a subset of its real portfolio. API: /api/v1/investors/yumeng-capital (get a free API key). More: the most active VC firms and new venture capital funds.